Pharma Articles
Renowned pharmaceutical firm executives and other experts from around the world write articles on current topics in the industry. The section of articles on the pharmaceutical sector focuses on contemporary and expanding challenges in fields such as pharmaceutical R&D, drug discovery, clinical trials, pharmaceutical production, biopharmaceuticals, and information technology.
The Outsourcing Advantage: Why Pharma’s Next Competitive Edge Will Be Built Through Ecosystems
The pharmaceutical industry is entering an era in which scale alone no longer guarantees advantage Scientific complexity is rising product lifecycles are shortening regulatory expectations are becoming more exacting and patients expect faster access to safe effective therapies
Automation Revolution: A Strategic Blueprint for Modern Industrial Production
In the contemporary industrial landscape the fundamental architecture of manufacturing is undergoing a profound and irreversible transformation Historically the strength of an industrial enterprise was often measured by its physical scalespecifically
B2B Pharma Content Strategy for HCP Engagement and Multi-Channel Marketing
The pharmaceutical industry has entered a new era of healthcare professional HCP engagement Traditional sales representative visits and print materials are no longer sufficient to influence prescribing decisions or build lasting relationships with physicians pharmacists specialists
From Pipelines to Platforms: How AI Investments Are Transforming Biotech and Pharma’s Operating Model
Artificial intelligence has rapidly emerged as one of the defining themes in the pharmaceutical industry Over the last few years major drugmakers have announced a steady stream of investments partnerships and internal initiatives aimed at bringing AI into research and development manufacturing quali...
From a Nation of Comrades to VIP Individuals: The Paradigm Shift Called Precision Medicine
Every scientific era is defined by a central question For much of the twentieth century a simple but extraordinarily successful one guided medicine What do patients have in common That question shaped the entire healthcare ecosystem
Forgotten Biology: The Missing Link Behind Trial Outcomes
Clinical trials are often described as the science of uncertainty and that uncertainty is expected It is how evidence is built However not all uncertainty is scientific In many cases it arises when the biological context of an intervention is not carried through into the study population
How to Build a Compliant Pharma Email Strategy Using Automation Tools
Email is not a marketing channel in pharma Its a controlled communication environment Every message sentto a healthcare professional a distributor or even an internal stakeholdersits within a framework of regulations Unlike retail or SaaS marketing you dont get the luxury of experimentation without...
Biosimilar Market Access: Why Execution Gaps Cost Companies Hundreds of Millions
The biosimilar market in represents one of the most significant commercial opportunities in the pharmaceutical industrys history The US Food and Drug Administration FDA approved a record biosimilars in spanning oncology immunology ophthalmology and metabolic disease including insulin biosimilars...
Boost Your Pharma Conference ROI: Proven Tactics to Increase Qualified Leads
You are already aware of what happens in a pharma conference if you have attended one in recent times The halls are crowded the chatting does not cease and at the end of the day the list of contacts that your team has gathered is dozens sometimes hundreds long
Preclinical Development for Topical Drug Products
Topical drug products are designed to deliver therapeutic agents directly to the skin for local effects However the skin is a highly complex organ with an effective barrier system primarily due to the stratum corneum SC which restricts the penetration of most molecules
